Stratview Research has published a new report titled “HIV Diagnosis Market” which is segmented By Product (Consumables, Assay, Kits and Reagents, Other Consumables, Instruments, Software, Services), By Test Type (Antibody tests [HIV-1 screening tests {ELISA, Rapid Tests, Home Access Dried Blood Spot}], HIV-1 confirmatory tests {Western Blot Tests, Indirect Immune Fluorescent Antibody Assays (IFA), Line Immunoassays (LIA), Radio-Immunoprecipitation Assays (RIPA)}, HIV-2 & Group O diagnostic tests], Viral identification assays, CD4 testing, Viral load testing, Early infant diagnosis), By Application (Diagnostic Laboratories, Hospitals, Blood Banks, Home care settings, Others), and By Region (North America, Europe, Asia-Pacific, and Rest of the World).

As per the study, the market was expected to reach USD 1348.18 billion by 2028 from USD 845.50 billion in 2022 at a CAGR of 6.84% during the forecast period of 2023-2028.

Diagnosis of a blood sample to check the presence of HIV (Human Immunodeficiency Virus) in humans is regarded as an HIV diagnosis.

The diagnosis of HIV helps to detect the presence of HIV that causes AIDS (Acquired Immunodeficiency Syndrome). This is carried out by conducting tests on saliva, serum, or urine samples. These tests can detect antigens, antibodies, or RNA.

Report Highlights

This report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can affect the industry’s market dynamics. It provides a thorough analysis of the market segments which include products, applications, and competitor analysis.

The market is bifurcated into various segments. Below given is the segment-wise analysis -

Test Type Trends

The market is segmented into antibody tests, viral identification assays, CD4 testing, viral load testing, and early infant diagnosis.

Among these, the Antibody Tests Segment accounted for the largest market share and is likely to register a healthy CAGR during the forecast timeline.

This is mainly ascribed to the increasing awareness about HIV, rising technological advancements in HIV diagnosis, and growing blood donations, thereby bolstering segment growth.

Which Region is expected to remain the largest market?

The North American market held the highest market share and is estimated to grow at a steady CAGR during the assessment period.

This can be attributed to the presence of a technologically advanced healthcare framework, supportive reimbursement policies, relatively higher healthcare expenditure in research and development, and the high prevalence of HIV thereby proliferating the industry growth in the region.

Who are the Key Players in the Market?

This report provides market intelligence most comprehensively. It also provides critical insights into the key players active in the market, which will enable strategic decision-making for the existing market players as well as those willing to enter the market. The following are the key players active in the HIV Diagnosis Market:

• Abbott (The U.S)
• Apogee Flow Systems Ltd. (UK)
• Atomo Diagnostics (Australia)
• BD Biosciences (The U.S)
• Beckman Coulter Inc. (The U.S)
• BioMerieux SA (France)
• Cepheid (The U.S)
• ChemBio Diagnostics Inc. (The U.S)
• Daktari Diagnostics, Inc. (The U.S)
• Hologic Inc. (The U.S)

Key questions answered by the report.

• What is the projected CAGR for revenue from the HIV Diagnosis Market during the forecast period?
• What would the market be valued at by 2028?
• What is a major driving factor for the growth of the market?
• Which region accounted for the largest revenue share in the HIV Diagnosis Market?
• Which are the major market players?

Custom Research:

Stratview Research delivers custom research services across sectors. In case of any custom research requirements, please send your inquiry to sales@stratviewresearch.com. Or connect with our experts at +1-313-307-4176.

About Us

Stratview Research is a global market research firm, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients insightful market data to aid strategic decision-making. These exclusive reports are the result of exclusive research methodology and are available for key industries such as chemicals, composites, advanced materials, technology, renewable energy, and more.